Basic Information
LncRNA/CircRNA Name | SNHG5 |
Synonyms | NA |
Region | GRCh38_6:85660950-85678736 |
Ensemble | ENSG00000203875 |
Refseq | NR_003038 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | Breast Cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | MCF10A, MCF7, T47D, BT474, BT549, MDA-MB-468, andMDAMB231 cell lines, breast cancer tissue and paired adjacent normal breast tissue |
Expression Pattern | up-regulated |
Function Description | small nucleolar RNA host gene 5 (SNHG5) promotes breast cancer cell proliferation both in vitro and in vivo, and depletion of SNHG5 significantly led to cell-cycle arrest at G1 phase. Accumulating evidence has shown that many lncRNA transcripts could function as competing endogenous RNAs (ceRNAs) by competitively binding common microRNAs (miRNAs). We found that SNHG5 acts as a sponge for miR-154-5p, reducing its ability to repress proliferating cell nuclear antigen (PCNA). SNHG5 promoted breast cancer proliferation and cell-cycle progression by upregulation of PCNA expression. Clinically, we observed an increased SNHG5 expression in breast cancer, whereas miR-154-5p was decreased in breast cancer tissues compared with the adjacent normal breast tissues. Furthermore, the SNHG5 expression was significantly negatively correlated with miR-154-5p expression. |
Pubmed ID | 31255976 |
Year | 2019 |
Title | SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis |
External Links
Links for SNHG5 | GenBank HGNC NONCODE |
Links for Breast Cancer | OMIM COSMIC |